Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study

A. Cuneo, G. Follows, G.M. Rigolin, A. Piciocchi, A. Tedeschi, L. Trentin, A.M. Perez, M. Coscia, L. Laurenti, G. Musuraca, L. Farina, A.R. Delgado, E.M. Orlandi, P. Galieni, F.R. Mauro, C. Visco, A. Amendola, A. Billio, R. Marasca, A. ChiarenzaV. Meneghini, F. Ilariucci, M. Marchetti, S. Molica, F. Re, G. Gaidano, M. Gonzalez, F. Forconi, S. Ciolli, A. Cortelezzi, M. Montillo, L. Smolej, A. Schuh, T.A. Eyre, B. Kennedy, K.M. Bowles, M. Vignetti, J. De La Serna, C. Moreno, R. Foà, P. Ghia, GIMEMA Party, European Research Initiative on CLL (ERIC), UK CLL forum

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1209-1217
Number of pages9
JournalHaematologica
Volume103
Issue number7
DOIs
Publication statusPublished - 2018

Keywords

  • bendamustine
  • chlorambucil
  • fludarabine
  • ibrutinib
  • rituximab, adult
  • aged
  • anemia
  • Article
  • autoimmune hemolytic anemia
  • cancer chemotherapy
  • cancer staging
  • chronic lymphatic leukemia
  • comorbidity
  • creatinine clearance
  • cytopenia
  • drug efficacy
  • drug safety
  • encephalitis
  • febrile neutropenia
  • female
  • human
  • lung infection
  • major clinical study
  • male
  • neutropenia
  • observational study
  • overall survival
  • progression free survival
  • rash
  • salvage therapy
  • thrombocytopenia
  • very elderly

Cite this

Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study. / Cuneo, A.; Follows, G.; Rigolin, G.M.; Piciocchi, A.; Tedeschi, A.; Trentin, L.; Perez, A.M.; Coscia, M.; Laurenti, L.; Musuraca, G.; Farina, L.; Delgado, A.R.; Orlandi, E.M.; Galieni, P.; Mauro, F.R.; Visco, C.; Amendola, A.; Billio, A.; Marasca, R.; Chiarenza, A.; Meneghini, V.; Ilariucci, F.; Marchetti, M.; Molica, S.; Re, F.; Gaidano, G.; Gonzalez, M.; Forconi, F.; Ciolli, S.; Cortelezzi, A.; Montillo, M.; Smolej, L.; Schuh, A.; Eyre, T.A.; Kennedy, B.; Bowles, K.M.; Vignetti, M.; De La Serna, J.; Moreno, C.; Foà, R.; Ghia, P.; Party, GIMEMA; (ERIC), European Research Initiative on CLL; forum, UK CLL.

In: Haematologica, Vol. 103, No. 7, 2018, p. 1209-1217.

Research output: Contribution to journalArticle

Cuneo, A, Follows, G, Rigolin, GM, Piciocchi, A, Tedeschi, A, Trentin, L, Perez, AM, Coscia, M, Laurenti, L, Musuraca, G, Farina, L, Delgado, AR, Orlandi, EM, Galieni, P, Mauro, FR, Visco, C, Amendola, A, Billio, A, Marasca, R, Chiarenza, A, Meneghini, V, Ilariucci, F, Marchetti, M, Molica, S, Re, F, Gaidano, G, Gonzalez, M, Forconi, F, Ciolli, S, Cortelezzi, A, Montillo, M, Smolej, L, Schuh, A, Eyre, TA, Kennedy, B, Bowles, KM, Vignetti, M, De La Serna, J, Moreno, C, Foà, R, Ghia, P, Party, GIMEMA, (ERIC), ERIOCLL & forum, UKCLL 2018, 'Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study', Haematologica, vol. 103, no. 7, pp. 1209-1217. https://doi.org/10.3324/haematol.2018.189837
Cuneo, A. ; Follows, G. ; Rigolin, G.M. ; Piciocchi, A. ; Tedeschi, A. ; Trentin, L. ; Perez, A.M. ; Coscia, M. ; Laurenti, L. ; Musuraca, G. ; Farina, L. ; Delgado, A.R. ; Orlandi, E.M. ; Galieni, P. ; Mauro, F.R. ; Visco, C. ; Amendola, A. ; Billio, A. ; Marasca, R. ; Chiarenza, A. ; Meneghini, V. ; Ilariucci, F. ; Marchetti, M. ; Molica, S. ; Re, F. ; Gaidano, G. ; Gonzalez, M. ; Forconi, F. ; Ciolli, S. ; Cortelezzi, A. ; Montillo, M. ; Smolej, L. ; Schuh, A. ; Eyre, T.A. ; Kennedy, B. ; Bowles, K.M. ; Vignetti, M. ; De La Serna, J. ; Moreno, C. ; Foà, R. ; Ghia, P. ; Party, GIMEMA ; (ERIC), European Research Initiative on CLL ; forum, UK CLL. / Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study. In: Haematologica. 2018 ; Vol. 103, No. 7. pp. 1209-1217.
@article{332281c7a68c4f68a4664be2094a76b2,
title = "Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study",
keywords = "bendamustine, chlorambucil, fludarabine, ibrutinib, rituximab, adult, aged, anemia, Article, autoimmune hemolytic anemia, cancer chemotherapy, cancer staging, chronic lymphatic leukemia, comorbidity, creatinine clearance, cytopenia, drug efficacy, drug safety, encephalitis, febrile neutropenia, female, human, lung infection, major clinical study, male, neutropenia, observational study, overall survival, progression free survival, rash, salvage therapy, thrombocytopenia, very elderly",
author = "A. Cuneo and G. Follows and G.M. Rigolin and A. Piciocchi and A. Tedeschi and L. Trentin and A.M. Perez and M. Coscia and L. Laurenti and G. Musuraca and L. Farina and A.R. Delgado and E.M. Orlandi and P. Galieni and F.R. Mauro and C. Visco and A. Amendola and A. Billio and R. Marasca and A. Chiarenza and V. Meneghini and F. Ilariucci and M. Marchetti and S. Molica and F. Re and G. Gaidano and M. Gonzalez and F. Forconi and S. Ciolli and A. Cortelezzi and M. Montillo and L. Smolej and A. Schuh and T.A. Eyre and B. Kennedy and K.M. Bowles and M. Vignetti and {De La Serna}, J. and C. Moreno and R. Fo{\`a} and P. Ghia and GIMEMA Party and (ERIC), {European Research Initiative on CLL} and forum, {UK CLL}",
year = "2018",
doi = "10.3324/haematol.2018.189837",
language = "English",
volume = "103",
pages = "1209--1217",
journal = "Haematologica",
issn = "0390-6078",
publisher = "NLM (Medline)",
number = "7",

}

TY - JOUR

T1 - Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study

AU - Cuneo, A.

AU - Follows, G.

AU - Rigolin, G.M.

AU - Piciocchi, A.

AU - Tedeschi, A.

AU - Trentin, L.

AU - Perez, A.M.

AU - Coscia, M.

AU - Laurenti, L.

AU - Musuraca, G.

AU - Farina, L.

AU - Delgado, A.R.

AU - Orlandi, E.M.

AU - Galieni, P.

AU - Mauro, F.R.

AU - Visco, C.

AU - Amendola, A.

AU - Billio, A.

AU - Marasca, R.

AU - Chiarenza, A.

AU - Meneghini, V.

AU - Ilariucci, F.

AU - Marchetti, M.

AU - Molica, S.

AU - Re, F.

AU - Gaidano, G.

AU - Gonzalez, M.

AU - Forconi, F.

AU - Ciolli, S.

AU - Cortelezzi, A.

AU - Montillo, M.

AU - Smolej, L.

AU - Schuh, A.

AU - Eyre, T.A.

AU - Kennedy, B.

AU - Bowles, K.M.

AU - Vignetti, M.

AU - De La Serna, J.

AU - Moreno, C.

AU - Foà, R.

AU - Ghia, P.

AU - Party, GIMEMA

AU - (ERIC), European Research Initiative on CLL

AU - forum, UK CLL

PY - 2018

Y1 - 2018

KW - bendamustine

KW - chlorambucil

KW - fludarabine

KW - ibrutinib

KW - rituximab, adult

KW - aged

KW - anemia

KW - Article

KW - autoimmune hemolytic anemia

KW - cancer chemotherapy

KW - cancer staging

KW - chronic lymphatic leukemia

KW - comorbidity

KW - creatinine clearance

KW - cytopenia

KW - drug efficacy

KW - drug safety

KW - encephalitis

KW - febrile neutropenia

KW - female

KW - human

KW - lung infection

KW - major clinical study

KW - male

KW - neutropenia

KW - observational study

KW - overall survival

KW - progression free survival

KW - rash

KW - salvage therapy

KW - thrombocytopenia

KW - very elderly

U2 - 10.3324/haematol.2018.189837

DO - 10.3324/haematol.2018.189837

M3 - Article

VL - 103

SP - 1209

EP - 1217

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 7

ER -